The modified Glasgow Prognostic Score (mGPS) can guide decisions for immunotherapy treatment beyond progression.
European journal of cancer (Oxford, England : 1990)
View this publicationEuropean journal of cancer (Oxford, England : 1990)
View this publicationEuropean journal of immunology
View this publicationNature reviews. Urology
View this publicationFrontiers in immunology
View this publicationHuman pathology
View this publicationImmunity
View this publicationJournal of cancer research and clinical oncology
View this publicationPharmaceutics
View this publicationEuropean urology
View this publicationJournal of cellular and molecular medicine
View this publication